Cyclosporine: Short-Term Use in Inflammatory Dermatoses

Overview / Definition Cyclosporine is a calcineurin inhibitor that suppresses T-cell activation and proliferation. It is commonly utilized in dermatology for the treatment of severe inflammatory dermatoses, particularly when rapid disease control is necessary. This medication is typically reserved for short-term use due to its side effect profile. Epidemiology Cyclosporine is indicated for various inflammatory skin disorders. While exact epidemiological data on its use in dermatology is limited, it is recognized as a valuable option for patients who have not responded adequately to conventional therapies. The following conditions are commonly treated with cyclosporine: Psoriasis Atopic Dermatitis Vesiculobullous Disorders (e.g., pemphigus vulgaris) Severe Contact Dermatitis Pathophysiology / Mechanism Cyclosporine functions by inhibiting the enzyme calcineurin, which is crucial for T-cell activation. This inhibition leads to: Reduced interleukin-2 (IL-2) production Decreased proliferation of T-lymphocytes Suppression of inflammatory cytokines This mechanism results in effective control of the immune-mediated processes underpinning various inflammatory dermatoses. Clinical Presentation Patients treated with cyclosporine may present with a range of inflammatory skin conditions. Key clinical features to note include: Psoriasis: Plaque formation, erythema, and scaling. Atopic Dermatitis: Erythematous pruritic lesions, often with lichenification. Pemphigus Vulgaris: Flaccid blisters and erosions on mucosal and cutaneous surfaces. Rapid improvement in skin lesions is often observed within weeks of initiating cyclosporine therapy. Diagnosis / Workup The diagnosis of inflammatory dermatoses that warrant cyclosporine treatment is primarily clinical, based on the characteristic features of the disease. However, the following steps may be necessary: Skin biopsy for histological confirmation if the diagnosis is uncertain. Laboratory tests to evaluate baseline renal function and